R1 RCM (NASDAQ:RCM) Posts Quarterly Earnings Results, Misses Expectations By $0.04 EPS

R1 RCM (NASDAQ:RCM) released its earnings results on Tuesday. The healthcare provider reported ($0.05) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.01) by ($0.04), Briefing.com reports. The firm had revenue of $656.80 million during the quarter, compared to the consensus estimate of $640.93 million. R1 RCM had a negative return on equity of 1.44% and a negative net margin of 1.68%. The business’s revenue was up 14.7% on a year-over-year basis.

R1 RCM Stock Performance

NASDAQ RCM traded up $0.01 on Wednesday, reaching $14.28. 1,116,113 shares of the company’s stock traded hands, compared to its average volume of 3,478,877. The firm has a market cap of $6.03 billion, a price-to-earnings ratio of -142.70 and a beta of 0.84. The stock has a 50 day moving average price of $14.18 and a 200-day moving average price of $13.28. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.84 and a current ratio of 1.84. R1 RCM has a fifty-two week low of $8.87 and a fifty-two week high of $15.12.

Analysts Set New Price Targets

A number of brokerages recently issued reports on RCM. Leerink Partnrs lowered R1 RCM from a “strong-buy” rating to a “hold” rating in a research note on Thursday, August 1st. Leerink Partners cut R1 RCM from an “outperform” rating to a “market perform” rating and dropped their price objective for the stock from $17.00 to $14.30 in a research note on Thursday, August 1st. Jefferies Financial Group downgraded R1 RCM from a “buy” rating to a “hold” rating in a report on Thursday, August 1st. Morgan Stanley lowered shares of R1 RCM from an “overweight” rating to an “equal weight” rating in a report on Thursday, August 8th. Finally, Stephens downgraded shares of R1 RCM from an “overweight” rating to an “equal weight” rating in a research note on Thursday, August 1st. Thirteen investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $15.41.

R1 RCM Company Profile

R1 RCM Inc provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers.